Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Hepatitis E Clinical Research Samples
Discovery Life Sciences provides the highest quality Hepatitis E Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Hepatitis E Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Advanced Data View:
Showing 69 of 69 total samples
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Detail 1 | Test 2 | Test Data 2 | Test 3 | Test Data 3 | Detail 3 | Product Details | Price | Buy | Blood Type | Symptoms | Hepatitis Serology | Acquired Infection Category | 3-Series HepB Vaccine | Other Testing Results | Co-Infections | Current Anti-Viral Therapy | Genotype | Additional Results | Sero HEV-IgG | Sero HEV-IgM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBP0000-EQ900108101110119DD | Hepatitis E | France | 2.00 | 2.00 | $75.00 | < -70C | 02-Nov-19 | Bio-Evolution PCR Tps Reel | Positive | Bio-Evolution ORF2 PCR | Genotype 3c | Real-Time PCR | 502,000 cps/mL | Sequencing of the ORF2 region | $75.00 | Unknown | |||||||||||||||||||
| BBS0005-CV900029051031418DD | Hepatitis E | Vietnam | 1.00 | 7.00 | $200.00 | 36 Y | Female | <-70C | 14-Mar-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Fatigue; Jaundice | HEV IgM + | U/A | Yes | ALT: 109 U/L | AST: 218 U/L | Bilirubin: 179 umol/L | Creatinine: 62 umol/L Hepatitis E 8-Mar-18 | None | None | ||||||||||||||
| BBS0005-CV900029057041718DD | Hepatitis E | Vietnam | 1.00 | 7.00 | $200.00 | 39 Y | Male | <-70C | 17-Apr-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 108 U/L | AST: 179 U/L | Bilirubin: 273 umol/L | Creatinine: 89 umol/L Hepatitis E 30-Mar-18 | None | None | ||||||||||||||
| BBS0005-CV900040657080318DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 4.00 | $200.00 | 47 Y | Female | Non-Hispanic | <-70C | 03-Aug-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Fatigue | HEV IgM + | U/A | No | ALT: 894 U/L | AST: 108 U/L | Bilirubin: 17.1 umol/L | Creatinine: 43 umol/L Hepatitis E 1-Aug-18 | None | None | ||||||||||||
| BBS0005-CV900048152122717DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 9.00 | $200.00 | 53 Y | Female | Non-Hispanic | <-70C | 27-Dec-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 90 U/L | AST: 46 U/L | Bilirubin: 38.5 umol/L | Creatinine: 74 umol/L Hepatitis E 26-Dec-17 | None | None | ||||||||||||
| BBS0005-CV900049297080618DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 6.00 | $200.00 | 41 Y | Male | Non-Hispanic | <-70C | 06-Aug-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Fatigue | HEV IgM + | U/A | No | ALT: 182 U/L | AST: 541 U/L | Bilirubin: 404 umol/L | Creatinine: 102 umol/L Hepatitis E 2-Aug-18 | None | None | ||||||||||||
| BBS0005-CV900054341041718DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 6.00 | $200.00 | 52 Y | Male | Non-Hispanic | <-70C | 17-Apr-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | HEV IgM + ; HBsAg + | U/A | No | ALT: 289 U/L | AST: 114 U/L | Bilirubin: 475 umol/L | Creatinine: 148 umol/L Hepatitis E and Hepatitis B 7-Apr-18 | HBV treatment naive | None | ||||||||||||
| BBS0005-CV900056405122117DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 5.00 | $200.00 | 65 Y | Female | Non-Hispanic | <-70C | 21-Dec-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 46 U/L | AST: 78 U/L | Bilirubin: 20.2 umol/L | Creatinine: 59 umol/L Hepatitis E 15-Dec-17 | None | None | ||||||||||||
| BBS0005-CV900062664091218DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 5.00 | $200.00 | 38 Y | Female | Non-Hispanic | <-70C | 12-Sep-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 590 U/L | AST: 114 U/L | Bilirubin: 119 umol/L | Creatinine: 64 umol/L Hepatitis E 6-Sep-18 | HBV treatment naive | None | ||||||||||||
| BBS0005-CV900066837082118DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 7.00 | $200.00 | 69 Y | Female | Non-Hispanic | <-70C | 21-Aug-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Fatigue | HEV IgM + | U/A | No | ALT: 508 U/L | AST: 174 U/L | Bilirubin: 251 umol/L | Creatinine: 51 umol/L Hepatitis E 17-Aug-18 | HBV since 2015, treatment naive | None | ||||||||||||
| BBS0005-CV900066839052818DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 9.00 | $200.00 | 60 Y | Male | Non-Hispanic | <-70C | 28-May-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 482 U/L | AST: 387 U/L | Bilirubin: 558 umol/L | Creatinine: 110 umol/L Hepatitis E 21-May-18 | None | None | ||||||||||||
| BBS0005-CV900067717071817DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 12.00 | $200.00 | 34 Y | Male | Non-Hispanic | <-70C | 18-Jul-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Fatigue; Jaundice | HEV IgM + 12-Jul-17 | U/A | No | | ALT: 123 U/L | AST: 352 U/L | Bilirubin: 34 umol/L | Serum Creatinine: 84 umol/L 14-Jul-17 | None | None | ||||||||||||
| BBS0005-CV900067719070717DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 10.00 | $200.00 | 51 Y | Male | Non-Hispanic | <-70C | 07-Jul-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | HEV IgM + 6-Jul-17 | U/A | No | | ALT: 1851 U/L | AST: 2196 U/L | Bilirubin: 60 umol/L | Serum Creatinine: 82 umol/L 30-Jun-17 | None | None | ||||||||||||
| BBS0005-CV900067723071417DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 14.00 | $200.00 | 70 Y | Male | Non-Hispanic | <-70C | 14-Jul-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Fatigue; Jaundice | HEV IgM + 13-Jul-17 | U/A | No | | ALT: 857 U/L | AST: 1133 U/L | Bilirubin: 101.9 umol/L | Serum Creatinine: 82 umol/L 10-Jul-17 | None | None | ||||||||||||
| BBS0005-CV900074051052518DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 7.00 | $200.00 | 34 Y | Male | Non-Hispanic | <-70C | 25-May-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 212 U/L | AST: 148 U/L | Bilirubin: 137 umol/L | Creatinine: 82 umol/L Hepatitis E 21-May-18 | None | None | ||||||||||||
| BBS0005-CV900074052090718DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 3.00 | $200.00 | 40 Y | Male | Non-Hispanic | <-70C | 07-Sep-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Fatigue | HEV IgM + | U/A | No | ALT: 281 U/L | AST: 233 U/L | Bilirubin: 176 umol/L | Creatinine: 75 umol/L Hepatitis E 30-Sep-18 | None | None | ||||||||||||
| BBS0005-CV900076254070617DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 10.00 | $200.00 | 68 Y | Female | Non-Hispanic | <-70C | 06-Jul-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | HEV IgM + 29-Jun-17 | U/A | No | | ALT: 743 U/L | AST: 531 U/L | ALP: 136 U/L | Bilirubin: 258 umol/L | Serum Creatinine: 82 umol/L 29-Jun-17 | None | None | ||||||||||||
| BBS0005-CV900077906052818DD | Hepatitis E | Vietnam | 0.5 mL Serum | 1.00 | 9.00 | $200.00 | 69 Y | Male | Non-Hispanic | <-70C | 28-May-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Jaundice | HEV IgM + | U/A | No | ALT: 280 U/L | AST: 100 U/L | Bilirubin: 299 umol/L | Creatinine: 77 umol/L Hepatitis E 16-May-18 | None | None | ||||||||||||
| BBS0005-CV900081418072117DD | Hepatitis E | Vietnam | 1.00 | 12.00 | $200.00 | 68 Y | Female | <-70C | 21-Jul-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Fatigue; Jaundice | HEV IgM + 20-Jul-17 | U/A | No | | ALT: 201 U/L | AST: 478 U/L | Bilirubin: 58.5 umol/L | Serum Creatinine: 78 umol/L 21-Jul-17 | None | None | ||||||||||||||
| BBS0005-CV900087492070717DD | Hepatitis E | Vietnam | 1.00 | 14.00 | $200.00 | 29 Y | Female | <-70C | 07-Jul-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Fatigue; Jaundice | HEV IgM + 6-Jul-17 | U/A | No | | ALT: 210 U/L | AST: 233 U/L | Bilirubin: 87 umol/L | Serum Creatinine: 76 umol/L 30-Jun-17 | None | None | ||||||||||||||
| BBS0005-CV900087495060917DD | Hepatitis E | Vietnam | 1.00 | 10.00 | $200.00 | 47 Y | Male | <-70C | 09-Jun-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Fatigue; Jaundice | HEV IgM + 6-Jun-17 | U/A | No | | ALT: 186 U/L | AST: 751 U/L | Bilirubin: 82.7 umol/L | Serum Creatinine: 92 umol/L 8-Jun-17 | None | None | ||||||||||||||
| BBS0005-CV900087509072617DD | Hepatitis E | Vietnam | 1.00 | 9.00 | $200.00 | 63 Y | Female | <-70C | 26-Jul-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue | HEV IgM + 25-Jul-17 | U/A | No | | ALT: 203 U/L | AST: 365 U/L | ALP: 186 U/L | LDH: 236 U/L | Bilirubin: 8.3 umol/L | Serum Creatinine: 82 umol/L 18-Jul-17 | None | None | ||||||||||||||
| BBS0005-CV900089038070617DD | Hepatitis E | Vietnam | 1.00 | 10.00 | $200.00 | 44 Y | Male | <-70C | 06-Jul-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | HEV IgM + 30-Jun-17 | U/A | No | | ALT: 82 U/L | AST: 156 U/L | Bilirubin: 18 umol/L | Serum Creatinine: 49 umol/L 4-Jul-17 | None | None | ||||||||||||||
| BBS0005-CV900090149060717DD | Hepatitis E | Vietnam | 1.00 | 8.00 | $200.00 | 55 Y | Male | <-70C | 07-Jun-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Fatigue; Jaundice | HEV IgM + 5-Jun-17 | U/A | No | | ALT: 1793 U/L | AST: 1680 U/L | ALP: 169 U/L | Bilirubin: 304 umol/L | Serum Creatinine: 79 umol/L 2-Jun-17 | None | None | ||||||||||||||
| DSP3800-EQ900054901122215DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 3.00 | $75.00 | 63 Y | Male | Unknown | <-70C | 22-Dec-15 | Altona HEV RT-PCR Kit | 534 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 0.77 IU/mL | Positive | $75.00 | Unknown | 3f | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900054902120416DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 21.00 | $75.00 | 64 Y | Male | Unknown | <-70C | 04-Dec-16 | Altona HEV RT-PCR Kit | 23,100 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 38.5 IU/mL | Positive | $75.00 | Unknown | 3c | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900054903100715DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 15.00 | $75.00 | 55 Y | Male | Unknown | <-70C | 07-Oct-15 | Altona HEV RT-PCR Kit | 1,070 copies/mL | WANTAI HEV-IgM Elisa | Negative | WANTAI HEV-IgG Elisa | Negative | $75.00 | Unknown | 3i | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | ||||||||||||||
| DSP3800-EQ900054904032216DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 1.00 | $75.00 | 19 Y | Male | Unknown | <-70C | 22-Mar-16 | Altona HEV RT-PCR Kit | 1,140 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | Negative | $75.00 | Unknown | 3f | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | ||||||||||||||
| DSP3800-EQ900054905050316DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 6.00 | $75.00 | 59 Y | Male | Unknown | <-70C | 03-May-16 | Altona HEV RT-PCR Kit | 15,600 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | Negative | $75.00 | Unknown | 3 | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | ||||||||||||||
| DSP3800-EQ900054906031115DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 51 Y | Male | Unknown | <-70C | 11-Mar-15 | Altona HEV RT-PCR Kit | 8,930 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 0.39 IU/mL | Positive | $75.00 | Unknown | 3f | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900054907092116DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 52 Y | Male | Unknown | <-70C | 21-Sep-16 | Altona HEV RT-PCR Kit | <100 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 3.19 IU/mL | Positive | $75.00 | Unknown | U/A | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900054908031215DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 47 Y | Male | Unknown | <-70C | 12-Mar-15 | Altona HEV RT-PCR Kit | 4,440 copies/mL | WANTAI HEV-IgM Elisa | Negative | WANTAI HEV-IgG Elisa | Negative | $75.00 | Unknown | 3 | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | ||||||||||||||
| DSP3800-EQ900054909110315DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 44 Y | Male | Unknown | <-70C | 03-Nov-15 | Altona HEV RT-PCR Kit | 243,000 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 0.90 IU/mL | Positive | $75.00 | Unknown | 3f | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900054910111315DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 7.00 | $75.00 | 41 Y | Male | Unknown | <-70C | 13-Nov-15 | Altona HEV RT-PCR Kit | <100 copies/mL | WANTAI HEV-IgM Elisa | Negative | WANTAI HEV-IgG Elisa | Negative | $75.00 | Unknown | U/A | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | ||||||||||||||
| DSP3800-EQ900054911120116DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 54 Y | Male | Unknown | <-70C | 01-Dec-16 | Altona HEV RT-PCR Kit | <100 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 54.33 IU/mL | Positive | $75.00 | Unknown | U/A | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900061984032916DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 13.00 | $75.00 | 38 Y | Male | Unknown | <-70C | 29-Mar-16 | Altona HEV RT-PCR Kit | 12,300 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 0.79 IU/mL | Positive | $75.00 | Unknown | 3 | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900061985042516DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 13.00 | $75.00 | 31 Y | Male | Unknown | <-70C | 25-Apr-16 | Altona HEV RT-PCR Kit | 12,600 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 0.74 IU/mL | Positive | $75.00 | Unknown | 3f | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900061986090215DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 8.00 | $75.00 | 70 Y | Male | Unknown | <-70C | 02-Sep-15 | Altona HEV RT-PCR Kit | 7,500 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 0.33 IU/mL | Positive | $75.00 | Unknown | 3c | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900061987100215DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 27 Y | Male | Unknown | <-70C | 02-Oct-15 | Altona HEV RT-PCR Kit | 162 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 0.90 IU/mL | Positive | $75.00 | Unknown | U/A | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900061988111715DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 24 Y | Female | Unknown | <-70C | 17-Nov-15 | Altona HEV RT-PCR Kit | <100 copies/mL | WANTAI HEV-IgM Elisa | Negative | WANTAI HEV-IgG Elisa | Negative | $75.00 | Unknown | U/A | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | ||||||||||||||
| DSP3800-EQ900061989120815DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 54 Y | Male | Unknown | <-70C | 08-Dec-15 | Altona HEV RT-PCR Kit | <100 copies/mL | WANTAI HEV-IgM Elisa | Negative | WANTAI HEV-IgG Elisa | Negative | $75.00 | Unknown | U/A | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | ||||||||||||||
| DSP3800-EQ900061990012916DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 6.00 | $75.00 | 29 Y | Male | Unknown | <-70C | 29-Jan-16 | Altona HEV RT-PCR Kit | 2,430 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 0.61 IU/mL | Positive | $75.00 | Unknown | 3f | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900061991032516DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 5.00 | $75.00 | 53 Y | Male | Unknown | <-70C | 25-Mar-16 | Altona HEV RT-PCR Kit | <100 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 11.23 IU/mL | Positive | $75.00 | Unknown | U/A | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900061992020216DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 64 Y | Female | Unknown | <-70C | 02-Feb-16 | Altona HEV RT-PCR Kit | 4,760 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 5.14 IU/mL | Positive | $75.00 | Unknown | U/A | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900061993070115DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 23 Y | Male | Unknown | <-70C | 01-Jul-15 | Altona HEV RT-PCR Kit | 224 copies/mL | Sero HEV-IgM | U/A | Sero HEV IgG | U/A | $75.00 | Unknown | 3i | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | ||||||||||||||
| DSP3800-EQ900061994072015DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 53 Y | Male | Unknown | <-70C | 20-Jul-15 | Altona HEV RT-PCR Kit | 554 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 0.36 IU/mL | Positive | $75.00 | Unknown | 3f | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900061995081815DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 6.00 | $75.00 | 24 Y | Male | Unknown | <-70C | 18-Aug-15 | Altona HEV RT-PCR Kit | 44,900 copies/mL | WANTAI HEV-IgM Elisa | U/A | WANTAI HEV-IgG Elisa | Negative | $75.00 | Unknown | 3i | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | ||||||||||||||
| DSP3800-EQ900061996121815DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 42 Y | Male | Unknown | <-70C | 18-Dec-15 | Altona HEV RT-PCR Kit | <100 copies/mL | WANTAI HEV-IgM Elisa | Negative | WANTAI HEV-IgG Elisa | Negative | $75.00 | Unknown | U/A | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | ||||||||||||||
| DSP3800-EQ900071655051116DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 42 Y | Male | Unknown | <-70C | 11-May-16 | Altona HEV RT-PCR Kit | 1,360 copies/mL | WANTAI HEV-IgM Elisa | Negative | WANTAI HEV-IgG Elisa | Negative | $75.00 | Unknown | U/A | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | ||||||||||||||
| DSP3800-EQ900071656033016DD | Hepatitis E | France | Double Spun Plasma | 1.00 | 4.00 | $75.00 | 30 Y | Male | Unknown | <-70C | 30-Mar-16 | Altona HEV RT-PCR Kit | 369 copies/mL | WANTAI HEV-IgM Elisa | Positive | WANTAI HEV-IgG Elisa | 1.27 IU/mL | Positive | $75.00 | Unknown | U/A | HCV, HIV, HTLV, HBc, HBsAg Negative. Viral Genome Screening Negative. | |||||||||||||
| DSP3800-EQ900085129103012DD | Hepatitis E | France | 2.00 | 12.00 | $75.00 | < -70C | 30-Oct-12 | Bio-Evolution PCR Tps Reel | Positive | Bio-Evolution ORF2 PCR | Genotype 3 | Real-Time PCR | 2,940 cps/mL | Sequencing of the ORF2 region | $75.00 | Unknown | |||||||||||||||||||
| DSP3800-EQ900085130092612DD | Hepatitis E | France | 2.00 | 11.00 | $75.00 | < -70C | 26-Sep-12 | Bio-Evolution PCR Tps Reel | Positive | Bio-Evolution ORF2 PCR | Genotype 3f | Real-Time PCR | 165,000 cps/mL | Sequencing of the ORF2 region | $75.00 | Unknown | |||||||||||||||||||
| DSP3800-EQ900085131091712DD | Hepatitis E | France | 2.00 | 15.00 | $75.00 | < -70C | 17-Sep-12 | Bio-Evolution PCR Tps Reel | Positive | Bio-Evolution ORF2 PCR | Genotype 3f | Real-Time PCR | 2,440 cps/mL | Sequencing of the ORF2 region | $75.00 | Unknown | Neg | Neg HCV, HIV, HTLV, HBc et AgHBs Neg DGV Neg Syphilis Nég. Infection Réplicative à HEV | |||||||||||||||||
| DSP3800-EQ900085132100512DD | Hepatitis E | France | 2.00 | 13.00 | $75.00 | < -70C | 05-Oct-12 | Bio-Evolution PCR Tps Reel | Positive | Real-Time PCR | 132,000 cps/mL | Sequencing of the ORF2 region | $75.00 | Unknown | |||||||||||||||||||||
| DSP3800-EQ900085133101512DD | Hepatitis E | France | 2.00 | 16.00 | $75.00 | < -70C | 15-Oct-12 | Bio-Evolution PCR Tps Reel | Positive | Real-Time PCR | 1,710 cps/mL | $75.00 | Unknown | ||||||||||||||||||||||
| DSP3800-EQ900085134111212DD | Hepatitis E | France | 2.00 | 17.00 | $75.00 | < -70C | 12-Nov-12 | Bio-Evolution PCR Tps Reel | Positive | Real-Time PCR | 10,900 cps/mL | Sequencing of the ORF2 region | $75.00 | Unknown | |||||||||||||||||||||
| EDP0000-CV900029051031418DD | Hepatitis E | Vietnam | 1.00 | 9.00 | $200.00 | 36 Y | Female | <-70C | 14-Mar-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Fatigue; Jaundice | HEV IgM + | U/A | Yes | ALT: 109 U/L | AST: 218 U/L | Bilirubin: 179 umol/L | Creatinine: 62 umol/L Hepatitis E 8-Mar-18 | None | None | ||||||||||||||
| EDP0000-CV900029057041718DD | Hepatitis E | Vietnam | 1.25 | 6.00 | $200.00 | 39 Y | Male | <-70C | 17-Apr-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Abdominal pain; Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 108 U/L | AST: 179 U/L | Bilirubin: 273 umol/L | Creatinine: 89 umol/L Hepatitis E 30-Mar-18 | None | None | ||||||||||||||
| EDP0000-CV900040657080318DD | Hepatitis E | Vietnam | K2 EDTA Plasma | 1.00 | 7.00 | $200.00 | 47 Y | Female | Non-Hispanic | <-70C | 03-Aug-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Fatigue | HEV IgM + | U/A | No | ALT: 894 U/L | AST: 108 U/L | Bilirubin: 17.1 umol/L | Creatinine: 43 umol/L Hepatitis E 1-Aug-18 | None | None | ||||||||||||
| EDP0000-CV900048152122717DD | Hepatitis E | Vietnam | K2 EDTA Plasma | 1.00 | 9.00 | $200.00 | 53 Y | Female | Non-Hispanic | <-70C | 27-Dec-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 90 U/L | AST: 46 U/L | Bilirubin: 38.5 umol/L | Creatinine: 74 umol/L Hepatitis E 26-Dec-17 | None | None | ||||||||||||
| EDP0000-CV900049297080618DD | Hepatitis E | Vietnam | K2 EDTA Plasma | 1.00 | 8.00 | $200.00 | 41 Y | Male | Non-Hispanic | <-70C | 06-Aug-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Fatigue | HEV IgM + | U/A | No | ALT: 182 U/L | AST: 541 U/L | Bilirubin: 404 umol/L | Creatinine: 102 umol/L Hepatitis E 2-Aug-18 | None | None | ||||||||||||
| EDP0000-CV900054341041718DD | Hepatitis E | Vietnam | K2 EDTA Plasma | 1.25 | 7.00 | $200.00 | 52 Y | Male | Non-Hispanic | <-70C | 17-Apr-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | HEV IgM + ; HBsAg + | U/A | No | ALT: 289 U/L | AST: 114 U/L | Bilirubin: 475 umol/L | Creatinine: 148 umol/L Hepatitis E and Hepatitis B 7-Apr-18 | HBV treatment naive | None | ||||||||||||
| EDP0000-CV900056405122117DD | Hepatitis E | Vietnam | 1.00 | 6.00 | $200.00 | 65 Y | Female | <-70C | 21-Dec-17 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 46 U/L | AST: 78 U/L | Bilirubin: 20.2 umol/L | Creatinine: 59 umol/L Hepatitis E 15-Dec-17 | None | None | ||||||||||||||
| EDP0000-CV900062664091218DD | Hepatitis E | Vietnam | K2 EDTA Plasma | 1.00 | 8.00 | $200.00 | 38 Y | Female | Non-Hispanic | <-70C | 12-Sep-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Abdominal pain; Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 590 U/L | AST: 114 U/L | Bilirubin: 119 umol/L | Creatinine: 64 umol/L Hepatitis E 6-Sep-18 | HBV treatment naive | None | ||||||||||||
| EDP0000-CV900066837082118DD | Hepatitis E | Vietnam | K2 EDTA Plasma | 1.00 | 9.00 | $200.00 | 69 Y | Female | Non-Hispanic | <-70C | 21-Aug-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Fatigue | HEV IgM + | U/A | No | ALT: 508 U/L | AST: 174 U/L | Bilirubin: 251 umol/L | Creatinine: 51 umol/L Hepatitis E 17-Aug-18 | HBV since 2015, treatment naive | None | ||||||||||||
| EDP0000-CV900066839052818DD | Hepatitis E | Vietnam | K2 EDTA Plasma | 1.00 | 9.00 | $200.00 | 60 Y | Male | Non-Hispanic | <-70C | 28-May-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 482 U/L | AST: 387 U/L | Bilirubin: 558 umol/L | Creatinine: 110 umol/L Hepatitis E 21-May-18 | None | None | ||||||||||||
| EDP0000-CV900074051052518DD | Hepatitis E | Vietnam | K2 EDTA Plasma | 1.00 | 8.00 | $200.00 | 34 Y | Male | Non-Hispanic | <-70C | 25-May-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Fatigue; Jaundice | HEV IgM + | U/A | No | ALT: 212 U/L | AST: 148 U/L | Bilirubin: 137 umol/L | Creatinine: 82 umol/L Hepatitis E 21-May-18 | None | None | ||||||||||||
| EDP0000-CV900074052090718DD | Hepatitis E | Vietnam | K2 EDTA Plasma | 1.00 | 5.00 | $200.00 | 40 Y | Male | Non-Hispanic | <-70C | 07-Sep-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Decreased appetite; Fatigue | HEV IgM + | U/A | No | ALT: 281 U/L | AST: 233 U/L | Bilirubin: 176 umol/L | Creatinine: 75 umol/L Hepatitis E 30-Sep-18 | None | None | ||||||||||||
| EDP0000-CV900077906052818DD | Hepatitis E | Vietnam | K2 EDTA Plasma | 1.00 | 9.00 | $200.00 | 69 Y | Male | Non-Hispanic | <-70C | 28-May-18 | HEV IgM | ELISA | Positive | HEV IgM | $200.00 | Unknown | Jaundice | HEV IgM + | U/A | No | ALT: 280 U/L | AST: 100 U/L | Bilirubin: 299 umol/L | Creatinine: 77 umol/L Hepatitis E 16-May-18 | None | None |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.